Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-01-24 @ 4:53 PM
Study NCT ID:
NCT01161667
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2010-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions
Sponsor:
Roxane Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NARA-T25-PVFS-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Elizabeth Ernst, Cirector, Drug Regulatory and Medical Affairs
Old Organization:
Roxane Laboratories, Inc.